Search | IOVS | ARVO Journals

View

Showing 1 – 8 of 8

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Short-Term Effects of Intravitreal Bevacizumab in Contrast Sensitivity of Patients with Diabetic Macular Edema and Optimizing Glycemic Control

Augusto Motta; Maria Teresa BC Bonanomi; Daniel Araujo Ferraz; Rony Carlos Preti; Raafay Sophie; Flavio Mac Cord Medina; Maria Fernanda Abalem; Marcia Queiroz; Sergio Luis G Pimentel; Walter Yukihiko Takahashi; Francisco Max Damico

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4835. doi:

ARVO Annual Meeting Abstract July 2018

Outcomes of Intravitreal Bevacizumab for Diabetic Macular Edema in Patients with Visual Acuity Worse than 20/200

Flavio Mac Cord Medina; Carolina Tagliari Estacia; Aluisio Rosa Gameiro Filho; Mário Martins dos Santos Motta; Aderbal Alburquerque Junior; Augusto Motta

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1902. doi:

ARVO Annual Meeting Abstract April 2014

Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Pilot Study.

Augusto Motta; Lisa Vasquez; Daniel Araujo Ferraz; Marcia S Queiroz; Maria Teresa BC Bonanomi; Walter Y Takahashi

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1762. doi:

ARVO Annual Meeting Abstract April 2014

Contrast sensitivity evaluation in high-risk treatment-naïve proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal Ranibizumab.

Daniel Araujo Ferraz; Lisa Vasquez; Augusto Motta; Rony C Preti; Raafay Sophie; Millena Gomes Bittencourt; Mario L R Monteiro; Walter Y Takahashi

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4414. doi:

ARVO Annual Meeting Abstract April 2014

Association of the Y402H polymorphism of CFH gene with response of exudative AMD to intravitreal VEGF inhibitors in the Brazilian population

Flavio mac cord Medina; Augusto Lopes Alves da Motta; Walter Y Takahashi; Pedro Carlos Carricondo; Mario Martins dos Santos Motta; Monica B Melo; Jose Paulo C Vasconcellos

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2214. doi:

ARVO Annual Meeting Abstract June 2013

Intravitreal Ranibizumab Combined with Panretinal Photocoagulation in Patients with Treatment-Naive Proliferative Diabetic Retinopathy

Daniel Ferraz; Raafay Sophie; Millena Bittencourt; Rony Preti; Lisa Vazquez; Augusto Motta; Mostafa Hanout; Yasir Sepah; Quan Dong Nguyen; Walter Takahashi

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5761. doi:

ARVO Annual Meeting Abstract March 2012

Comparative efficacy of combined treatment including intravitreal injection of 0.5 mg of Lucentis (ranibizumab) and laser photocoagulation for patients with Proliferative Diabetic Retinopathy (PDR): Short Term Results

Daniel Ferraz, Sr.; Lisa Vasquez, Sr.; Augusto Motta, Sr.; Rony Preti, Sr.; Celso Morita, Sr.; Otacilio O. Maia Júnior, Sr.; Walter Takahashi, Sr.

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3281. doi:

ARVO Annual Meeting Abstract March 2012

Structural and Functional Macular Evaluation in Proliferative Diabetic Retinopathy patients treated using Panretinal Photocoagulation Combined with Intravitreal Bevacizumab Injections

Rony C. Preti; Lisa M. Ramirez; Andre C. Barros; Augusto A. Motta; Celso Morita; Otacilio O. Maia Junior; Daniel A. Ferraz; Walter Y. Takahashi

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):357. doi:

Advertisement